Personalized T-cell therapy for advanced lung or solid tumors
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This Phase 1 study tests a lab-made immune cell treatment made from your own blood cells (T cells) to fight advanced lung cancer or other solid tumors. You may be eligible if your tumor can be biopsied and the lab can successfully prepare T cells that strongly recognize and attack your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced lung cancer or another solid tumor, and your doctors can take a biopsy sample
- You are expected to live more than 12 weeks
- Your liver score is below 7 (Child-Pugh-Turcotte), and your heart, lungs, liver, and kidneys work well enough for treatment
- You must have enough of your own modified immune cells made for the trial, with at least 20% showing the right target and proven cancer-killing in testing
- You have not had prior gene therapy, and you do not have certain serious active infections (like HIV, hepatitis B/C, or other significant viral or fungal infections)
- You are not pregnant or breastfeeding, and you are not taking higher-dose steroid medicines like prednisone at or above the trial threshold
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
This trial tests a personalized treatment using your own immune cells (T cells) that are specially trained to find and attack lung cancer cells. It may help people with advanced or relapsed lung cancer who have not improved with standard treatments.
This early-phase study tests a personalized treatment made from your own immune cells to attack solid tumors that have not responded to standard care. If you qualify, the team will collect blood cells, prepare the therapy, and give it back to you with close monitoring for safety and early signs of benefit.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer that has progressed after standard therapy. You would have surgery to collect a tumor sample, then receive your expanded immune cells back as an infusion.
This trial tests a personalized treatment that uses your own immune cells, modified to recognize and attack your cancer. It may help people with advanced solid tumors who have not improved with standard treatments.
Hear when a new Solid Tumor, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.